Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
News: Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
All NewsEconomyCurrencies & ForexEconomic EventsCryptocurrenciesCybersecurityPress Releases

China's Sinopharm starts Phase III trial of COVID-19 vaccine in Bahrain

08/10/2020 | 11:29am EDT
FILE PHOTO: A woman holds a small bottle labeled with a

Chinese state-owned pharmaceutical company Sinopharm has begun Phase III clinical trials of a COVID-19 vaccine in Bahrain, after launching similar trials in the United Arab Emirates last month, Bahrain's health ministry said on Monday.

The human trial, which launched in the UAE capital Abu Dhabi in mid-July, is a partnership between Sinopharm's China National Biotec Group (CNBG) and Abu Dhabi-based artificial intelligence and cloud computing company Group 42 (G42).

G42 Healthcare CEO Ashish Koshy said expanding the trial to the small island state of Bahrain will increase the numbers of participants on a par with trials underway in nations with much larger populations.

The study, which uses an inactivated vaccine, will include around 6,000 citizens and resident volunteers in Bahrain over 12 months, the health ministry said.

No COVID-19 vaccine has yet been approved for commercial use.

The trial in the UAE, which was expanded from Abu Dhabi to include another centre in Sharjah emirate, on Thursday reached a milestone of 5,000 vaccinations, a joint statement from the trial organisers said.

Bahrain, with a population of 1.5 million, has recorded more than 44,000 cases of the new coronavirus and 162 deaths.

(Writing by Lisa Barrington; Editing by Kirsten Donovan)

ę Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
SINOPHARM GROUP CO., LTD. 0.83% 24.2 End-of-day quote.28.31%
US DOLLAR / DIRHAM (USD/AED) 0.00% 3.6728 Delayed Quote.0.00%
Latest news "Economy & Forex"
10:29aWall Street drops on inflation jitters, led by tech stocks
10:22aNew York wins Brexit swaps shake-up as clearing stays in London
10:20aTech selloff in focus as Nasdaq backs further away from record highs
10:17aU.S. waives environmental rule to ease Mid-Atlantic fuel shortages
10:16aEnergy stocks drag down TSX
10:08aExclusive-Tesla puts brake on Shanghai land buy as U.S.-China tensions weigh - sources
10:07aAmerica's mask makers face post-pandemic meltdown
10:03a'Do you want Tesla to accept Doge?' Musk asks Twitter users
10:03aELON MUSK : 'Do you want Tesla to accept Doge?' Musk asks Twitter users
10:02aRFA TO EPA : Allow E15 to Help Fill Void Created by Colonial Pipeline Shutdown
Latest news "Economy & Forex"